← TrialMatch
HomeTrials

Effect of Maternal Voice on Physiological Indicators and Feeding Performance

This study aimed to determine the effect of maternal voice on physiological indicators and oral feeding performance in preterm infants. Hypothesis 1 (H1): Preterm infants who listen to their mother's voice throughout the full oral feeding process have higher oxygen saturation levels than those who do not. Hypothesis 2

Condition(s)Preterm, Oral Feeding Performance
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThis study aimed to determine the effect of maternal voice on physiological indicators and oral feeding performance in preterm infants. Hypothesis 1 (H1): Preterm infants who listen to their mother's voice throughout the full oral feeding process have higher oxygen saturation levels than those who do not. Hypothesis 2 (H2): Preterm infants who listen to their mother's voice throughout the full oral feeding process have lower heart rates than those who do not. Hypothesis 3 (H3): Preterm infants exposed to maternal voice throughout the full oral feeding process have lower respiratory rates than those who are not exposed. Hypothesis 4 (H4): Preterm infants exposed to maternal voice throughout the full oral feeding process have better feeding maturation than those who are not exposed. Hypothes
Who can participateInclusion Criteria: * Preterm infants born at gestational age ≥28 weeks and ≤34 weeks * Infants who are ≥30 postmenstrual weeks old at the time of enrollment * Infants weighing ≥1000 grams at the time of enrollment * Mothers aged 18 years or older * Preterm infants who have passed the hearing screening test * Infants whose mothers can provide an average of at least 30 ml of expressed breast milk daily during the study period. * Mothers who are Turkish speakers. * Infants for whom the decision to transition from enteral feeding to full oral feeding has been made for the first time jointly by the physician and nurse Exclusion Criteria: * Preterm infants with congenital anomalies. * Infants with a family history of congenital hearing loss. * Infants diagnosed with intraventricular hemorrhage
Ages1 Day to 28 Days
SexAll
Accepts healthy volunteersYes
Lead sponsorAcibadem University
LocationsIstanbul, Turkey (Türkiye)
Start date2025-08-10
NCT IDNCT07068581
Official listinghttps://clinicaltrials.gov/study/NCT07068581

🔍 Search all trials →